4.0
May 30, 2024
Current employee, more than 1 year
Raleigh, NC
Recommend
CEO approval
Business Outlook
Pros
More responsive that typical big pharmaceutical company
Cons
They just purchased sales reps from Novartis so who knows what the next 12 months may bring